Project Main Details
2010-08-30 15:14:19 GMT 2010-09-01 09:00:00 (GMT -08:00) Pacific Time (US & Canada) Yes (click here to learn more about ) Closed 0 0 0 direct invitation(s) have been sent by the voice seeker resulting in 0 audition(s) and/or proposal(s) so far. Voice123 SmartCast is seeking 20 auditions and/or proposals for this project (approx.) Invitations sent by SmartCast have resulted in 0 audition(s) and/or proposal(s) so far.
• Audio files must be delivered via FTP/Dropbox/Google Drive/cloud
The DNAarray from CombiMatrix Diagnostics…
COMBINING GENOME-WIDE POWER WITH PATIENT-FOCUSED SERVICE
As a physician that treats patients with Cancer, you are well aware that patients often appear with very similar clinical presentations; they may be close in age, be in the same general health, and carry many of the same symptoms. They may also have initial diagnostic tests performed that yields similar results.
For instance, if you treat breast cancer patients, you may see 3 women that appear to have the same overall patient profile. They are :
early stage, invasive ductal carcinoma
and have a gene expression recurrence score in the intermediate range
Based on the similar clinical presentation, and after consultation with each patient, each had the same course of treatment. You are well aware that it is difficult to predict what type of outcome each patient will have to specific treatments. Some respond well to certain options, while others may fail.
We are all well aware that the era of personalized medicine is upon us. Now, with DNAarray technology from CombiMatrix Diagnostics, we can differentiate these patients like never before.
For instance, when looking at our 3 patients….we can identify a molecular sub-type category:
(Label Each patient with the following),
Luminal A – Favorable Prognosis - GREEN
Luminal B – Less Favorable Prognosis - YELLOW
Basal or Complex – Poor Prognosis – RED
CONTEXT PROVERB – forest from the trees – still need this
CombiMatrix Diagnostics, with its unique ability to run its array-based platform on tumor tissue from Formalin-Fixed, paraffin-embedded tissue, has now made it feasible to evaluate copy number changes in a wide variety of cancer types.
The DNAarray Breast Profile, HER2 PRO and Tumor Profile tests are performed on readily available archived tumor specimens from formalin fixed paraffin-embedded tissue. The DNAarray Heme profile is run on cells from peripheral blood, and provides the individualized molecular make-up for the various leukemias and lymphomas.
With the DNAarray, you get the the genome-wide views of traditional cytogenetics testing combined with the high resolution, sensitivity and specificity of FISH, all in one test.
COMBINING GENOME-WIDE POWER WITH PROBE-LIKE PRECISION
Simply put, DNAarray testing provides a comprehensive analysis of the entire patient tumor, and when combined with routine diagnostic testing, it can provide added clinical information that yields value to both physician and patient.
EXPERIENCE THE DNAarray difference from CombiMatrix Diagnostics !
Voice123 Team Comments
Voice123 consultations with this voice seeker regarding this project and/or other projects by this voice seeker, via phone, chat, and/or email.
This project - phone.
Previous projects - phone.
This project - email or chat.
Previous projects - email or chat.
Corporate web site for this voice-seeker confirmed by Voice123
Note: Voice123 strives to establish the legitimacy of all projects posted. However, Voice123 subscribers and users are responsible for confirming information stated by prospective voice seekers, agents and/or clients. Voice123 subscribers and users assume all liability for use of any information found through Voice123, or any of its publications.
This page contains the most important details of this project. If you find the information on this project inaccurate or inappropriate, please let us know by contacting us.